The Society for Neuro-Oncology and the European Association of Neuro-Oncology are pleased to announce the 3rd Annual Highlights of EANO/SNO 2024 webinar, where leading experts will discuss the most notable and innovative abstract presentations from the 19th Meeting of the European Association of Neuro-Oncology (EANO 2024) held in Glasgow, UK, and the 29th Annual Meeting of the Society for Neuro-Oncology (SNO 2024) held in Houston, TX.

Webinar on "Highlights of SNO & EANO 2024 Annual Meetings"
Friday, March 7, 2025, from 6:30 to 7:30 PM CET (12:30 – 1:30 PM ET)

Moderators:
Susan Short, Leeds, UK, and Giuseppe Minniti, Rome, IT (EANO)
Humsa Venkatesh, Boston, USA, and Shawn Hervey-Jumper, San Francisco, USA (SNO)

Presenters:
- Phase 3 STELLAR study shows eflornithine improves overall survival (OS) and progression free survival (PFS) in patients with recurrent 2021 WHO astrocytoma, IDH-mutant grade 3, Howard Coleman, Salt Lake City, USA

- Investigation of glioblastoma neuron-tumor networks with rabies-based retrograde tracing, Brainstem neuromodulatory neurons promote glioma growth locally and via long-range projections to midline and cortical structures, Ekin Reyhan, Heidelberg, Germany

- Reciprocal links between methionine metabolism, DNA repair and therapy resistance in glioblastoma, Navyateja Korimer, Michigan, USA

 - Usefulness of circulating tumor DNA (ctDNA) from cerebrospinal fluid (CSF) for prognosis of patients with recurrent high-grade glioma, Subhiksha Nandakumar, New York, USA

- Integrated Spatially Resolved Transcriptomics and Electrophysiology Unraveled the Architectural Heterogeneity of Neuronal-Glioma Interfaces, Dieter Henrik Heiland, Erlangen, Germany

BOOK NOW